Loading…
IQVIA acquired Quest Diagnostics' minority stake in Q2 Solutions, a central laboratory services joint venture, for $760 million. Quest will remain a preferred provider of lab testing services.
Quest Diagnostics signed a multi-year agreement with Siemens Healthineers to procure up to 120 Atellica Solution immunoassay analysers for 19 laboratories in the US, including a highly automated lab in Clifton, New Jersey.
Quest Diagnostics has signed a definitive agreement to acquire Cleveland HeartLab from equity investors including Cleveland Clinic. The transaction is expected to close in Q4 2017.